PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.\', \'Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.\', \'Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.\', \'Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.\', \'Departments of Medicine and Global Health, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.\', \'Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.\', \'Department of Pediatrics, Stony Brook Children\'s, Stony Brook, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa885
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32594142
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Coronavirus Disease 2019 (COVID-19) Pharmacologic Treatments for Children: Research Priorities and Approach to Pediatric Studies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all